SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Globe Life Inc. (GL) trades at a trailing P/E of 10.3, forward P/E of 9.7. Trailing earnings yield is 9.73%, forward earnings yield 10.35%. PEG 0.91 (Peter Lynch undervalued ≤1.0). Graham Number is $154.53.
Criteria proven by this page:
- VALUE (62/100, Pass) — P/E is below market average (10.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.91); analyst target implies upside (+11%); earnings yield beats bond yields (9.73%).
- Forward P/E 9.7 (down from trailing 10.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.91 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 9.73% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 10.35% as earnings recover.
- Analyst consensus target $164.50 (+11% upside) — modest upside expected.
Overall SharesGrow Score: 68/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
62/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GL
Valuation Multiples
P/E (TTM)10.3
Forward P/E9.7
PEG Ratio0.91
Forward PEG1.05
P/B Ratio2.00
P/S Ratio1.93
EV/EBITDA8.8
Per Share Data
EPS (TTM)$14.36
Forward EPS (Est.)$15.35
Book Value / Share$73.90
Revenue / Share$74.19
FCF / Share$15.51
Yields & Fair Value
Earnings Yield9.73%
Forward Earnings Yield10.35%
Dividend Yield0.77%
Graham Number$154.53
SharesGrow IV$341.46 (+130.4%)
Analyst Target$164.50 (+11%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
16.1 |
1.83 |
1.94 |
2.25 |
0.76% |
| 2017 |
7.3 |
0.04 |
1.69 |
2.54 |
0.65% |
| 2018 |
12.0 |
-0.24 |
1.55 |
1.95 |
0.85% |
| 2019 |
15.1 |
1.25 |
1.57 |
2.54 |
0.65% |
| 2020 |
13.8 |
-13.71 |
1.15 |
2.13 |
0.78% |
| 2021 |
9.3 |
1.60 |
1.11 |
1.87 |
0.84% |
| 2022 |
13.2 |
0.53 |
2.99 |
2.26 |
0.68% |
| 2023 |
11.9 |
1.01 |
2.58 |
2.12 |
0.73% |
| 2024 |
8.7 |
0.50 |
1.76 |
1.62 |
0.91% |
| 2025 |
9.7 |
0.51 |
1.89 |
1.89 |
0.76% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.49 |
$3.93B |
$550M |
14% |
| 2017 |
$12.22 |
$4.16B |
$1.45B |
35% |
| 2018 |
$6.08 |
$4.3B |
$701M |
16.3% |
| 2019 |
$6.83 |
$4.53B |
$760.79M |
16.8% |
| 2020 |
$6.82 |
$4.74B |
$731.77M |
15.4% |
| 2021 |
$7.22 |
$5.11B |
$744.96M |
14.6% |
| 2022 |
$7.47 |
$5.21B |
$894.39M |
17.2% |
| 2023 |
$10.07 |
$5.45B |
$970.76M |
17.8% |
| 2024 |
$12.63 |
$5.78B |
$1.07B |
18.5% |
| 2025 |
$14.06 |
$6B |
$1.16B |
19.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$15.35 |
$15.03 – $15.46 |
$6.39B |
$6.3B – $6.44B |
7 |
| 2027 |
$16.50 |
$16.25 – $16.78 |
$6.76B |
$6.56B – $6.87B |
7 |
| 2028 |
$18.13 |
$17.75 – $18.56 |
$7.23B |
$7.23B – $7.23B |
3 |
| 2029 |
$19.80 |
$19.12 – $20.10 |
$7.59B |
$7.39B – $7.68B |
1 |
